Gene · 7498
Papers4,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hyperuricemia remission after colorectal cancer surgery for colorectal cancer patients. | Sci Rep | 2023 | 37914834 | PubTator, text mining | PubMed |
| Sex Differences in the Preventive Effect of Cardiovascular and Metabolic Therapeutics on Dementia. | Biomol Ther (Seoul) | 2023 | 37899743 | PubTator, text mining | PubMed |
| Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4). | Pharmaceuticals (Basel) | 2023 | 37895896 | PubTator, text mining | PubMed |
| Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease. | Nutrients | 2023 | 37892555 | PubTator, text mining | PubMed |
| Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases. | Biomolecules | 2023 | 37892201 | PubTator, text mining | PubMed |
| Epithelial Transport in Disease: An Overview of Pathophysiology and Treatment. | Cells | 2023 | 37887299 | PubTator, text mining | PubMed |
| Does dietary nitrate boost the effects of caloric restriction on brain health? Potential physiological mechanisms and implications for future research. | Nutr Metab (Lond) | 2023 | 37880786 | PubTator, text mining | PubMed |
| The effect of lipid metabolism disorder on patients with hyperuricemia using Multi-Omics analysis. | Sci Rep | 2023 | 37875599 | PubTator, text mining | PubMed |
| Corrigendum to "Natural mutations of human XDH promote the nitrite (NO2-)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?" [Redox Biol. 4 (67) (2023) 102864]. | Redox Biol | 2023 | 37867029 | PubTator, text mining | PubMed |
| Prevalence of hyperuricaemia among adults from Ningxia Hui Autonomous Region, China: a cross-sectional study. | BMJ Open | 2023 | 37852763 | PubTator, text mining | PubMed |
| Association of serum uric acid with prognosis in patients with myocardial infarction: an update systematic review and meta-analysis. | BMC Cardiovasc Disord | 2023 | 37848854 | PubTator, text mining | PubMed |
| Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges. | Biomark Insights | 2023 | 37846373 | PubTator, text mining | PubMed |
| The role of high fat diet on serum uric acid level among healthy male first degree relatives of type 2 diabetes mellitus. | Sci Rep | 2023 | 37845387 | PubTator, text mining | PubMed |
| How hypoxia affects microbiota metabolism in mice. | Front Microbiol | 2023 | 37840721 | PubTator, text mining | PubMed |
| Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection. | Redox Biol | 2023 | 37839355 | PubTator, text mining | PubMed |
| Biodegradation of Inosine and Guanosine by Bacillus paranthracis YD01. | Int J Mol Sci | 2023 | 37833910 | PubTator, text mining | PubMed |
| Characterization and Comparative Analysis of the Complete Plastomes of Five Epidendrum (Epidendreae, Orchidaceae) Species. | Int J Mol Sci | 2023 | 37833887 | PubTator, text mining | PubMed |
| Association between elevated serum uric acid levels and high estimated glomerular filtration rate with reduced risk of low muscle strength in older people: a retrospective cohort study. | BMC Geriatr | 2023 | 37821826 | PubTator, text mining | PubMed |
| Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review. | Drugs | 2023 | 37819612 | PubTator, text mining | PubMed |
| Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies. | Front Mol Biosci | 2023 | 37818101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7498/papers?page=19